Piramal Pharma Limited

NSEI:PPLPHARMA Stock Report

Market Cap: ₹389.2b

Piramal Pharma Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure3.8yrs

Recent management updates

Recent updates

₹284 - That's What Analysts Think Piramal Pharma Limited (NSE:PPLPHARMA) Is Worth After These Results

Oct 26
₹284 - That's What Analysts Think Piramal Pharma Limited (NSE:PPLPHARMA) Is Worth After These Results

Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt

Oct 25
Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt

Here's Why Piramal Pharma (NSE:PPLPHARMA) Has A Meaningful Debt Burden

Jul 14
Here's Why Piramal Pharma (NSE:PPLPHARMA) Has A Meaningful Debt Burden

Estimating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Jun 17
Estimating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

We Think That There Are Issues Underlying Piramal Pharma's (NSE:PPLPHARMA) Earnings

May 21
We Think That There Are Issues Underlying Piramal Pharma's (NSE:PPLPHARMA) Earnings

It's A Story Of Risk Vs Reward With Piramal Pharma Limited (NSE:PPLPHARMA)

Mar 26
It's A Story Of Risk Vs Reward With Piramal Pharma Limited (NSE:PPLPHARMA)

Estimating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Feb 28
Estimating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Earnings Update: Here's Why Analysts Just Lifted Their Piramal Pharma Limited (NSE:PPLPHARMA) Price Target To ₹161

Feb 02
Earnings Update: Here's Why Analysts Just Lifted Their Piramal Pharma Limited (NSE:PPLPHARMA) Price Target To ₹161

Calculating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Nov 09
Calculating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Calculating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Aug 11
Calculating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

CEO

Piramal Pharma has no CEO, or we have no data on them.

Board Members

NamePositionTenureCompensationOwnership
Nandini Piramal
Executive Chairperson4.7yrs₹42.02m0.13%
₹ 513.7m
Vivek Valsaraj
President2.8yrs₹24.77mno data
Peter DeYoung
CEO of Piramal Global Pharma & Director4.7yrs₹42.40m0.033%
₹ 126.8m
Neeraj Bharadwaj
Non-Executive Director4.1yrsno datano data
Subramanian Ramadorai
Independent Non-Executive Director3.8yrs₹4.35m0.0020%
₹ 7.8m
Sridhar Gorthi
Independent Non-Executive Director2.7yrs₹4.20mno data
Vibha Rishi
Independent Non-Executive Director2.3yrs₹4.25mno data
Peter Stevenson
Independent Non-Executive Additional Director2.7yrs₹3.80mno data
Jairaj Purandare
Independent Non Executive Director3.8yrs₹4.55mno data

3.8yrs

Average Tenure

58yo

Average Age

Experienced Board: PPLPHARMA's board of directors are considered experienced (3.8 years average tenure).